Compound details
Epimedin K
| Compound ID | CDAMM02031 |
|---|---|
| Common name | Epimedin K | IUPAC name | [5-acetyloxy-6-[5-acetyloxy-3-hydroxy-2-[5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-4-oxo-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-3-yl]oxy-6-methyloxan-4-yl]oxy-3,4-dihydroxyoxan-2-yl]methyl acetate |
| Molecular formula | C45H56O23 |
| Retention time | 17.85 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 965.329 | Theoretical mz | 965.328 |
| Error | 0.34 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.0835 |
| Inchi key | AHIXHBMUHIBLGS-KQYAEQGENA-N |
|---|---|
| Smiles | O=C(OCC1OC(OC2C(O)C(OC=3C(=O)C4=C(O)C=C(OC5OC(CO)C(O)C(O)C5O)C(=C4OC3C=6C=CC(OC)=CC6)CC=C(C)C)OC(C)C2OC(=O)C)C(OC(=O)C)C(O)C1O)C |
| Superclass | Phenylpropanoids and polyketides |
| Class | Flavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SEA |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| P15692 | VEGFA | Vascular endothelial growth factor A | T20761 | SEA |
| P05230 | FGF1 | Acidic fibroblast growth factor | T18639 | SEA |
| P09038 | FGF2 | Basic fibroblast growth factor | T31621 | SEA |
| O76074 | PDE5A | Phosphodiesterase 5A | T07663 | SwissTargetPrediction |
| P60568 | IL2 | Interleukin-2 | T61698 | SEA |
| P17931 | LGALS3 | Galectin-3 | T72038 | SEA |
| P14679 | TYR | Tyrosinase | T97035 | SEA |
| P20916 | MAG | Myelin-associated glycoprotein (by homology) | T95286 | SEA |
| Q9GZQ4 | NMUR2 | Neuromedin-U receptor 2 | T04210 | SEA |
| Q9NZ08 | ERAP1 | Endoplasmic reticulum aminopeptidase 1 | T72849 | SEA |
| P30837 | ALDH1B1 | Acetaldehyde dehydrogenase | T99641 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T20761 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P15692 | VEGFA |
| T20761 | DI0365 | Retinopathy | [ICD-11: 9B71] | P15692 | VEGFA |
| T20761 | DI0430 | Vascular system developmental anomaly | [ICD-11: LA90] | P15692 | VEGFA |
| T18639 | DI0081 | Chronic arterial occlusive disease | [ICD-11: BD4Z] | P05230 | FGF1 |
| T18639 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P05230 | FGF1 |
| T31621 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P09038 | FGF2 |
| T07663 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | O76074 | PDE5A |
| T07663 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | O76074 | PDE5A |
| T07663 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | O76074 | PDE5A |
| T07663 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | O76074 | PDE5A |
| T61698 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P60568 | IL2 |
| T61698 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P60568 | IL2 |
| T72038 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P17931 | LGALS3 |
| T72038 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P17931 | LGALS3 |
| T72038 | DI0252 | Melanoma | [ICD-11: 2C30] | P17931 | LGALS3 |
| T72038 | DI0302 | Non-alcoholic fatty liver disease | [ICD-11: DB92] | P17931 | LGALS3 |
| T72038 | DI0351 | Psoriasis | [ICD-11: EA90] | P17931 | LGALS3 |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T95286 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P20916 | MAG |
| T99641 | DI0396 | Substance abuse | [ICD-11: 6C40] | P30837 | ALDH1B1 |